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Abstract
Aim To report refractive error prevalence and visual
impairment in Republic of Ireland (henceforth ’Ireland’)
schoolchildren.
Methods The Ireland Eye Study examined 1626
participants (881 boys, 745 girls) in two age groups, 6–7
years (728) and 12–13 years (898), in Ireland between
June 2016 and January 2018. Participating schools were
selected by stratified random sampling, representing
a mix of school type (primary/postprimary), location
(urban/rural) and socioeconomic status (disadvantaged/
advantaged). Examination included monocular logarithm
of the minimum angle of resolution (logMAR) presenting
visual acuity (with spectacles if worn) and cycloplegic
autorefraction (1% Cyclopentolate Hydrochloride).
Parents completed a questionnaire to ascertain
participants’ lifestyle.
Results The prevalence of myopia (spherical equivalent
refraction (SER): ≤−0.50 D), hyperopia (SER: ≥+2.00 D)
and astigmatism (≤−1.00 DC) among participants aged
6–7 years old was 3.3%, 25% and 19.2%, respectively,
and among participants aged 12–13 years old was
19.9%, 8.9% and 15.9%, respectively. Astigmatic axes
were predominately with-the-rule. The prevalence of
’better eye’ presenting visual impairment (≥0.3 logMAR,
with spectacles, if worn) was 3.7% among younger and
3.4% among older participants. Participants in minority
groups (Traveller and non-white) were significantly more
likely to present with presenting visual impairment in the
’better eye’.
Conclusions The Ireland Eye Study is the first
population-based study to report on refractive error
prevalence and visual impairment in Ireland. Myopia
prevalence is similar to comparable studies of white
European children, but the levels of presenting visual
impairment are markedly higher than those reported for
children living in Northern Ireland, suggesting barriers
exist in accessing eye care.
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© Author(s) (or their
employer(s)) 2019. Re-use
permitted under CC BY-NC. No
commercial re-use. See rights
and permissions. Published
by BMJ.
To cite: Harrington SC,
Stack J, Saunders K, et al.
Br J Ophthalmol
2019;103:1112–1118.
1112

The WHO and the International Agency for the
Prevention of Blindness have identified refractive
error as the second leading cause of blindness (after
cataracts), and addressing this is a WHO Vision
2020 priority.1 2 Presenting visual acuity is accepted
as providing a better index of visual disability in
a community, as opposed to best corrected visual
acuity, as it includes those with uncorrected refractive error.2
Uncorrected refractive errors (myopia, hyperopia and astigmatism) result in reduced educational opportunities and employment options,
impacting the individual and the community.3 The

global burden and economic cost to society in lost
productivity due to uncorrected refractive error
are conservatively estimated at $269 billion per
year.4 5 Therefore the public health issue of uncorrected refractive error impacts on children’s education; uncorrected hyperopia and astigmatism are
associated with poorer educational attainment.6 7
Research suggests a wide global variation and a
dramatic increase in the prevalence of myopia from
the late 20th century onwards.8 This is particularly
evident in East Asia, where myopia is a growing
health issue with a prevalence of 80%–90% in
school leavers.9 Myopia prevalence is clearly influenced by ethnicity, but environment has also been
demonstrated to play a significant role in the onset
and progression of the condition.10 For example,
myopia prevalence among Chinese children living
in Singapore is significantly higher than among
Chinese children in Australia, and lower in white
children living in Australia than white children
in the UK.11 12 Rapid increases in myopia prevalence across diverse geographical locations reflect
the environmental role in child myopia susceptibility,13 14 and is particularly evident among children
in areas where lifestyle and living conditions have
been impacted by significant economic growth.15
The Ireland Eye Study (IES) is the first study to
examine the prevalence of refractive error in schoolaged children in Ireland. This report describes the
prevalence of refractive error and visual impairment
in children aged 6–7 years and 12–13 years. These
data provide the first opportunity to compare children’s refractive and visual status in Ireland with
that from other areas of the world.

Methods
Sampling protocol
Stratified random cluster sampling was employed
in selecting schools for participation. Schools were
stratified by socioeconomically disadvantaged/
advantaged status, urban/rural status and by primary
(pupils aged 4–12 years)/postprimary (pupils aged
12–18 years) status. Areas were categorised as ‘rural’
if the population density was less than ten persons
per hectare (10 000 square metres), in line with
previous studies.16 The Irish state supports schools
categorised as Delivering Equality of opportunity In
School (DEIS). The IES categorised socioeconomic
status by DEIS status: DEIS schools were defined
as socioeconomically disadvantaged, other schools
were defined as advantaged.17
Within each stratum, schools were randomly
selected from a complete list (sampling frame)
of schools provided by the Irish Department of
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Education and Skills. A sample size of 1500 (700 children aged
6–7 years old and 800 children aged 12–13 years old) was calculated using G*Power analysis based on the predicted prevalence
of myopia of 3%–5% for children aged 6–7 years old, with a 1%
SE, and 10% for children aged 12–13 years old with a 1.5% SE,
and an assumed participation rate of 75%.18

Ethnicity

Ethnicity of participants was assessed by the study coordinator and confirmed by the parent/guardian through self-report. Participants were categorised as either white, Traveller or
non-white (black, Asian and Arab subjects combined). Although
the Traveller community originally descended from the white
Irish population, they diverged from the settled population
approximately 360 years ago. High levels of autozygosity within
the Traveller community have implications for disease mapping
within Ireland.19 According to the 2016 Irish census, 9.9% of
children aged between 5 and 14 years were non-white.

Recruitment

Selected schools were contacted and, with agreement from school
principals, an information pack was distributed to parents/guardians of children aged 6–7 years in primary and 12–13 years in
postprimary schools. Each pack contained a letter of invitation
outlining the study, an information sheet explaining the testing
procedures, the study questionnaire and a consent form. Children for whom informed consent and child assent were received
were tested on school premises within school hours.
Testing included the following procedures:
1. Assessment of monocular distance visions (with spectacles if
worn) using the Good-Lite (Elgin, Illinois) Sloan letters logarithm of the minimum angle of resolution (logMAR) chart
at 3 m. Visual acuity was recorded using the by-letter scoring
system and recorded in logMAR notation. A light metre was
employed to ensure the test luminance did not fall below
120 cd/m2.
2. Cycloplegic autorefraction (Dong Yang Rekto ORK-11 Auto
Ref-Keratometer, Everview, Seoul, Korea) was used to determine refractive error.20 21 Cycloplegia was achieved,
postinstillation of one drop of topical anaesthetic (Minims
Proxymetacaine hydrochloride 0.5% w/v, Bausch & Lomb,
UK), using one drop of Cyclopentolate Hydrochloride
(Minims, 1% w/v, Bausch & Lomb). Non-white children were
administered two drops of Cyclopentolate Hydrochloride
5 min apart. Once it was established cycloplegia had been
achieved (pupillary reactions non-responsive to light and accommodation amplitude less than 2 D on push-up test), at
least 20 min after instillation of the eye-drops, autorefraction was carried out. The representative value for spherical
equivalent refraction (SER)—sphere plus half the cylindrical
value—was used in subsequent analysis.
The IES questionnaire was based on questionnaires used in
other international studies and with input from epidemiology,
dietetics and focus group user testing.18 22 Parents completed
a participant and parental history and a children’s lifestyle
questionnaire.

Definitions

To facilitate comparison with previous studies,18 22 23 the Refractive Error Study in Children (RESC) protocol was used to define
myopia and hyperopia. The SER of the right eye was used to
classify subjects as myopic (≤−0.50 dioptre sphere (DS) SER),

hyperopic (≥+2.00 DS) or emmetropic (>−0.50 DS and
<+2.00 DS).
Astigmatism was defined using negative cylinders as 1.00
dioptre cylinder (DC) or greater. With-the-rule (WTR) astigmatism was defined as cylinder axes from 1°−15° and from
165°−180°, against-the-rule astigmatism as axes 75°−105°, and
oblique (OBL) astigmatism as axes 16°−74° and 106°−164°.18 22 23
Visual impairment was defined as ≥0.3 logMAR (6/12
Snellen), in line with the RESC protocol.23 Presenting visual
impairment (PVI) was defined by acuity measures ≥0.3 logMAR,
with spectacles, if worn. PVI was reported for the ‘better eye’
and for ‘either eye’.

Statistical methodology

The Statistical Package for Social Sciences V.21.0 was used for
most analyses. Anonymised study data were entered directly into
the SPSS database. Statistical programming language R was used
to generate random numbers for the sampling procedure and to
calculate prevalence data CIs.
There was no significant difference in SER prevalence, astigmatism prevalence and cylindrical axis of orientation prevalence
between the right and left eyes in either age cohort (Pearson’s χ2,
all p<0.001). Right and left eye data were strongly correlated
for SER (Spearman’s rho coefficient, r=0.878, p<0.001),
astigmatism (Spearman’s rho coefficient, r=0.383, p<0.001)
and presenting vision (Spearman’s rho coefficient, r=0.795,
p<0.001). Hence, right eye data only are presented.
The risk factors for SER prevalence were identified using
multinomial logistic regression, controlling for age group, with
emmetropic (absence of significant refractive error, SER <+2.00
DS to >−0.50 DS) participants as the reference group. When
evaluating the risk factors for astigmatism, the reference group
was participants with astigmatic errors >−1.00 DC. The risk
factors for PVI were examined using those without PVI as the
reference group. P values ≤0.05 were regarded as significant.
Throughout, 95% CIs have been used.

Results

Fifty-four per cent of the schools on the initial list agreed to
participate in this study; additional schools were recruited from
the reserve list. School participation rates did not vary significantly with socioeconomic status, urban/rural status or location.
A total of 37 schools participated (23 primary schools, 14 postprimary schools), and data collection occurred between June
2016 and January 2018.
Within-school participation rates ranged from 64% to 100%,
with an 83.3% average participation rate. Of those invited to
participate, parental consent was obtained from 733 participants
aged 6–7 years old (51.8% male; mean age 6.7 years, SD 0.49)
and 901 participants aged 12–13 years old (56.1% male; mean
age 12.8 years, SD 0.48). All participants successfully completed
monocular visual acuity assessment, and 99.3% of participants
aged 6–7 years old and 99.7% aged 12–13 years old underwent
cycloplegic autorefraction and provided measures for both eyes.
The results from eight children who declined eye-drops were
excluded.
Figure 1 illustrates the non-normal distribution of SER in 2 D
intervals for both age groups (p<0.001, Kolmogorov-Smirnoff
test). The distributions show peaks around the mean. SER
was positively skewed in participants aged 6–7 years old
(skew=1.61) and negatively skewed in participants aged 12–13
years old (skew=−0.29). In the older age group, the distribution
of SER shifts towards less positive values (6–7 years mean=1.44
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Figure 1 Distribution of spherical equivalent refractive error (D) in children aged 6–7 years old (top image) and those aged 12–13 years old (bottom
image) in the Ireland Eye Study.
D; 12–13 years mean=0.38 D). There was a large variation in
SER in both age groups as evidenced by the relatively large SD
(figure 1). The difference in mean SER between the two age groups
was statistically significant (p<0.001, Mann-Whitney test).
Table 1 presents the prevalence of myopia, hyperopia, astigmatism, astigmatic axis and PVI plus CIs by age.
Myopia prevalence was significantly greater, and hyperopia
prevalence significantly lower, in the older participant group
compared with the younger group (p<0.001), but no significant
difference in astigmatism prevalence between age groups was
found. The predominant type of astigmatism was WTR in both
groups.
There was no significant difference in PVI prevalence (‘better
eye’ or ‘either eye’) between the younger and older participants.
Table 1 Prevalence of refractive error, astigmatic axis, and
presenting visual impairment in participants aged 6–7 years and
12–13 years in the Ireland Eye Study
Prevalence, right
eye

n

12–13 years, % (CI)

24

3.3 (2.2 to 4.9)

179

19.9 (17.4 to 22.7)

Hyperopia

182

25.0 (21.9 to 28.3)

80

8.9 (7.2 to 11.0)

Astigmatism

140

19.2 (16.5 to 22.3)

143

15.9 (13.5 to 18.4)

 WTR

112

80.0 (72.2 to 86.1)

109

77.3 (69.3 to 83.7)

 ATR

8

5.7 (2.7 to 11.3)

13

9.2 (5.2 to 15.6)

 OBL

20

14.3 (9.2 to 21.4)

19

13.5 (8.5 to 20.5)

Myopia

n

6–7 years, % (CI)

Astigmatic axis

PVI (better eye)

27

3.7 (2.5 to 5.4)

30

3.4 (2.3 to 4.8)

PVI (either eye)

65

8.9 (7.0 to 11.3)

75

8.4 (6.7 to 10.4)

ATR, against-the-rule; OBL, oblique; PVI, presenting visual impairment; WTR, withthe-rule.
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Myopia (83.3%, p<0.001) and hyperopia (10.0%, p=0.025)
were significantly associated with PVI in the ‘better eye’ among
older children. Astigmatism (70.4%, p<0.001) and myopia
(18.5%, p<0.001) were significantly associated with PVI in the
‘better eye’ among the younger age cohort.
Astigmatism (61.3%, p<0.001), myopia (60.3%, p<0.001)
and hyperopia (25.3%, p<0.001) were significantly associated with PVI in ‘either eye’ in the older age group. Astigmatism (63.6%, p<0.001) and hyperopia (53.0%, p=0.013) were
significantly associated with PVI in ‘either eye’ in participants
aged 6–7 years old.

Refractive data and demographic profile

In addition to age, the principal demographic study variables in
the IES were urban/rural status, gender, ethnicity and socioeconomic status (table 2).
Multinomial logistic regression examining the relationship between SER and the study demographic variables jointly
showed that myopia and hyperopia were significantly related to
age group (p<0.001) and ethnicity (see below) (p<0.001) but
not to gender, urban/rural status or socioeconomic status.
The presence of astigmatism was significantly associated with
socioeconomic disadvantage (p=0.02) and ethnicity (see below)
(p=0.028), but not gender, urban/rural status or age.
PVI in the ‘better eye’ was associated with urban living
(p=0.006), socioeconomic disadvantage (p=0.015) and ethnicity
(see below) (p=0.007), but not gender or age. PVI in ‘either eye’
was associated with urban living (p=0.017) and socioeconomic
disadvantage (p=0.049), but not ethnicity, gender or age.

Relationship of refractive error to ethnicity

Table 3 presents the prevalence of myopia, hyperopia and astigmatism, plus PVI prevalence, by ethnic group.
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Table 2

Ireland Eye Study principal demographic study variables
6–7 years, n (%)

12–13 years,
n (%)

 Male

377 (51.8)

504 (56.1)

 Female

351 (48.2)

394 (43.9)

 Urban

368 (50.5)

751 (83.6)

 Rural

360 (49.5)

147 (16.4)

Demographic variables
Gender

No PVI, n
Wearing/not wearing spectacles, n (%) (%)
 No spectacles: 628 (86.3)

Socioeconomic status
245 (33.7)

108 (12.0)

 Non-DEIS

483 (66.3)

790 (88.0)

582 (79.9)

708 (78.8)

 Traveller

65 (8.9)

86 (9.6)

 South Asian

22 (3.0)

15 (1.7)

 East Asian

21 (2.9)

30 (3.3)

 Black

31 (4.3)

49 (5.5)

 Arab

7 (1.0)

10 (1.1)

81 (11.2)

20 (3.2)

50 (79.4%)

13 (20.6)

4 (6.3)

 At school without spectacles: 28 (3.9)

22 (78.6%)

6 (21.4)

1 (3.6)

 No spectacles: 675 (69.6)

645 (95.6)

30 (4.4)

 Wearing spectacles: 124 (13.8)

114 (91.9)

10 (8.1)

14 (2.1)
1 (0.8)

61 (63.5)

35 (36.5)

15 (15.6)

PVI, presenting visual impairment.

Wearing and not wearing spectacles

104 (11.6)

DEIS, Delivering Equality of opportunity In School.

The prevalence of both myopia and hyperopia was significantly related to ethnicity (p<0.001), with significantly higher
prevalence of myopia and lower prevalence of hyperopia in
the non-white group (table 3). Astigmatism prevalence was
significantly higher in non-white participants (p=0.007). The
prevalence of PVI in the ‘better eye’ was significantly higher in
Traveller and non-white participants (p=0.007).

Relationship between astigmatism and ametropia

Astigmatism was significantly associated with hyperopia and
myopia (p<0.001). Among participants aged 6–7 years old,
46.7% of those with astigmatism were hyperopic and 5.5% were
myopic; conversely among participants aged 12–13 years old,
20.5% of those with astigmatism were hyperopic and 37.3%
were myopic.

Profile of spectacle wear in IES participants

Table 4 presents the profile of spectacle wear in IES participants.

Table 3

583 (92.8)

 At school without spectacles: 96 (10.7)

Non-white
 South Asian, East Asian, black
and Arab combined

45 (7.2)

 Wearing spectacles: 63 (8.8)
12–13 years

Ethnicity
 White

PVI
PVI ‘either ‘better
eye’, n
eye’, n
(%)
(%)

6–7 years

Living environment

 DEIS

Table 4 Profile of spectacle wear in Ireland Eye Study participants
aged 6–7 years old and 12–13 years old

The proportion of participants who presented wearing spectacles was 8.8% of participants aged 6–7 years old and 13.8% of
those aged 12–13 years old; however, of those who reported
that they had a current spectacle correction, a proportion did
not have their spectacles at school (3.9% of participants aged
6–7 years old and 10.7% of those aged 12–13 years old). The
refractive profile of participants who did not have their spectacles at school was mainly hyperopic (53.6%) in the younger
cohort and astigmatic (44.8%) or hyperopic (32.3%) in the older
age cohort (table 4).

Not having spectacles

The prevalence of PVI in the ‘better eye’ or PVI in ‘either eye’
among participants who reported no history of spectacle wear
was 3.2% and 7.2%, respectively, in the younger age group, and
2.1% and 4.4%, respectively, in the older age group.

PVI in the ‘better eye’

Of the 25 participants aged 6–7 years with PVI in the ‘better eye’,
20 reported no history of spectacle wear, 4 needed an updated
spectacle prescription and 1 participant did not have their spectacles at school. Of the 30 participants aged 12–13 years with
PVI in the ‘better eye’, 14 reported no history of spectacle wear,
1 participant needed a spectacle update and 15 participants did
not have their spectacles at school.

Prevalence of myopia, hyperopia, astigmatism and presenting visual impairment by ethnic grouping
White
6–7 years, % (CI)

Myopia

Traveller
12–13 years, % (CI)

6–7 years, % (CI)

Non-white
12–13 years, % (CI)

6–7 years, % (CI)

12–13 years, % (CI)
39.4 (30.1 to 49.5)

1.9 (1.0 to 3.5)

17.4 (14.7 to 20.4)

4.6 (1.2 to 13.8)

17.4 (10.4 to 27.5)

12.3 (6.4 to 21.9)

Hyperopia

25.8 (22.3 to 29.6)

9.5 (7.3 to 11.8)

35.4 (24.2 to 48.3)

11.6 (6.2 to 20.8)

11.1 (5.5 to 20.5)

3.8 (1.2 to 10.1)

Astigmatism

17.9 (14.9 to 21.3)

15.1 (12.6 to 18.0)

26.2 (16.4 to 38.8)

11.6 (6.1 to 20.8)

23.5 (15.1 to 34.4)

25.0 (17.3 to 34.6)

80.0 (44.2 to 96.5)

89.5 (65.5 to 98.2)

88.5 (68.7 to 96.9)

Astigmatic axis
 WTR

78.8 (69.5 to 86.0)

74.3 (64.7 to 82.1)

76.5 (48.0 to 92.2)

 ATR

6.7 (3.0 to 13.9)

11.4 (6.3 to 19.5)

5.9 (0.3 to 30.8)

 OBL

14.4 (8.6 to 23.0)

14.3 (8.5 to 22.8)

17.6 (4.7 to 44.2)

PVI (better eye)

2.1 (1.1 to 3.7)

3.3 (2.1 to 4.9)

13.8 (6.9 to 25.2)

PVI (either eye)

6.4 (4.6 to 8.7)

8.2 (6.3 to 10.5)

21.5 (12.7 to 33.8)

0.0
20.0 (3.5 to 55.8)

0.0

3.8 (0.2 to 21.6)

10.5 (1.9 to 34.5)

7.7 (1.3 to 26.6)

1.2 (0.1 to 7.2)

7.4 (3.0 to 16.0)

5.8 (1.2 to 10.1)

8.1 (3.6 to 6.6)

17.3 (10.1 to 27.6)

9.6 (5.0 to 17.4)

ATR, against-the-rule; OBL, oblique; PVI, presenting visual impairment; WTR, with-the-rule.
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Table 5

Ireland Eye Study presenting visual acuity in the right eye

Presenting visual
acuity

n

Mean
logMAR (SD) n

All

728

0.01 (0.16)*

898

−0.07 (0.20)

Boys

377

0.01 (0.15)†

504

−0.07 (0.21)†

6–7 years old

Mean
logMAR (SD)

12–13 years

Girls

351

0.01 (0.17)

394

−0.07 (0.19)

White

582

−0.01 (0.14)‡

708

−0.07 (0.20)§

Traveller

65

0.08 (0.24)

86

−0.07 (0.18)

Non-white

146

0.06 (0.24)

104

−0.04 (0.22)

639

−0.12 (0.14)

Emmetropia

522

0.00 (0.17)

Myopia ≤−0.50 DS

24

0.15 (0.20)¶ 179

0.07 (0.29)¶

Hyperopia ≥+2.00 DS 182

0.04 (0.16)¶ 80

0.03 (0.21)¶

Astigmatism ≥1 DC

0.11 (0.21)¶ 143

0.06 (0.23)¶

140

*Statistically significant difference between age groups (Mann-Whitney U test for
comparison of means in non-parametric data).
†No statistically significant gender difference (Mann-Whitney U test for comparison
of means in non-parametric data).
‡Statistically significant ethnic difference (Kruskal-Wallis test for comparison of
means in non-parametric data).
§No statistically significant ethnic difference (Kruskal-Wallis test for comparison of
means in non-parametric data).
¶Statistically significant difference in presenting vision compared with those
without refractive error (Mann-Whitney U test for comparison of means in nonparametric data).
DC, dioptre cylinder; DS, dioptre sphere; logMAR, logarithm of the minimum angle
of resolution.

PVI in ‘either eye’

Of the 64 participants aged 6–7 years with PVI in ‘either
eye’, 45 reported no history of spectacle wear, 13 required an
updated spectacle prescription and 6 did not have their spectacles at school. Of the 75 participants aged 12–13 years with
PVI in ‘either eye’, 30 reported no history of spectacle wear, 10
required an updated spectacle prescription and 35 did not have
their spectacles at school.
Of the 22 participants aged 6–7 years without PVI who
reported spectacle wear, but did not have their spectacles at
school, 14 were hyperopic and 8 were astigmatic. Of the 61
participants aged 12–13 years without PVI who did not have
their spectacles in school, 30 were hyperopic, 21 astigmatic,
9 myopic and 1 participant did not have a refractive error as
defined by the IES.
A history of spectacle wear was significantly associated with
white ethnicity (p=0.038), older age group (p<0.001) and
urban living conditions (p<0.001), but not gender or socioeconomic status. Attending school without their prescribed spectacles was associated with socioeconomic disadvantage (p=0.008),
older age group (p<0.001) and white ethnicity (p=0.016).
Table 5 presents the mean logMAR presenting visual acuity
for all participants and by gender and ethnicity. It also records
the relationship between refractive error and presenting visual
acuity. Traveller and non-white participants aged 6–7 years old
had significantly poorer presenting acuity compared with white
participants aged 6–7 years old (p=0.006). Participants with
refractive error had significantly poorer presenting visual acuity
compared with emmetropic participants (p<0.001 logistic
regression).

Discussion

Using similar protocols and methodology, the myopia prevalence
in Ireland schoolchildren (6–7 years 3.3%, 12–13 years 19.9%)
for the period June 2016–January 2018 was comparable with
1116

that reported in the UK Northern Ireland Childhood Errors of
Refraction (NICER) study (6–7 years 2.8%, 12–13 years 17.7%),
Aston Eye Study (AES) (6–7 years 5.7%, 12–13 years 18.6%),18 22
Poland (7 years 4.0%, 12 years 14.4%)24 and Australia (6 years
1.6%, 12 years 12.8%),25 26 and significantly lower than that
reported in China (5 years 5.7%, 15 years 78.4%).27 In line with
the majority of other studies, a significantly higher myopia prevalence was found in children aged 12–13 years old than those
aged 6–7 years old. An exception to this was the RESC study in
South Africa, where a relatively low and stable myopia prevalence was found with age (7 years 2.5%, 13 years 3.4%).28
Similar to the AES (South Asian: 6–7 years 10.8%, 12–13
years 36.8%; black: 6–7 years 11.4%, 12–13 years 27.5%),22 a
markedly higher myopia prevalence was found among non-white
children (IES: 6–7 years 12.3%, 12–13 years 39.4%) in the IES.
The IES myopia prevalence in the non-white ethnic groups was
as follows: East Asians: 6–7 years 14.3%, 12–13 years 46.7%;
South Asians: 6–7 years 9.1%, 12–13 years 40.0%; and black:
6–7 years 16.1%, 12–13 years 34.7%.
The IES hyperopia prevalence (6–7 years 25%, 12–13 years
8.9%) was broadly in line with Northern Ireland (6–7 years
26%, 12–13 years 14.7%),18 higher than Australia (6 years
13.2%, 12 years 5.0%),25 26 Poland (7 years 19.2%, 12 years
8.3%)24 and China (5 years 17%, 15 years 0.5%).27 The IES
hyperopia prevalence at 6–7 years was higher among the Traveller (35.4%) and white (25.8%) participants when compared
with non-white (11.1%) ethnic groups. Although hyperopia
prevalence was lower at 12–13 years among white (9.5%) and
Traveller (11.6%) participants, it was still significantly higher
than that of non-white (3.8%) participants.
The IES astigmatism prevalence (6–7 years 19.2%, 12–13
years 15.9%) was similar to that found in Northern Ireland
(6–7 years 24%, 12–13 years 20%),29 higher than Australia (6
years 7.6%, 12 years 9.4%)25 26 and considerably lower than that
reported by Dobson et al30 for Native American children (5–16
years 42%). Similar to Dobson et al,30 the IES found astigmatism
to be associated with socioeconomic disadvantage and hyperopia. The predominant cylindrical axis of astigmatism was WTR
(6–7 years 80%, 12–13 years 77.3%), similar to Dobson et al’s
report (98%).30 The NICER study reported the predominant
cylindrical astigmatism axes to be OBL (6–7 years 76%, 12–13
years 59%).29
The association between PVI and refractive error has been
well established by the RESC, NICER and Sydney myopia
studies.18 26 27 Internationally, PVI is accepted as providing an
indicator of visual disability in society,2 and the IES found a relatively high prevalence of PVI in the ‘better eye’ of the younger
participants (3.7%) compared with the closest comparator, the
NICER study (1.5%).18 The level of PVI in the ‘better eye’ was
higher than that reported in Australia (1.5%)25 and lower than
that detected in China (10.3%).27Participants from minority
groups (Traveller and non-white) in particular were more likely
to present with bilateral visual impairment in the IES (Traveller:
6–7 years 13.8% and 12–13 years 1.2%; non-white: 6–7 years
7.4% and 12–13 years 5.8%). As 71.4% of younger participants
and 40.0% of older children with PVI in the IES were previously
uncorrected, simple spectacle correction would address a considerable proportion of childhood PVI in our population. However,
the IES found a considerable number of children who demonstrated visual impairment despite wearing refractive correction
because their spectacle correction required updating. Similar to
Zhang et al,31 the ‘See well to learn well’ project reported inaccurate spectacle prescriptions to be common and recommended
annual refractions to address this issue.

Harrington SC, et al. Br J Ophthalmol 2019;103:1112–1118. doi:10.1136/bjophthalmol-2018-312573

Br J Ophthalmol: first published as 10.1136/bjophthalmol-2018-312573 on 12 October 2018. Downloaded from http://bjo.bmj.com/ on October 28, 2021 by guest. Protected by copyright.

Clinical science

The present study demonstrates an association between socioeconomic disadvantage and PVI which was not reflected in the
NICER study. Financial barriers have been cited as the primary
reason for non-attendance to eye care services or the failure to
purchase spectacles.32 In the UK (where the NICER study was
conducted) children are entitled to free eye examinations and
spectacle correction. This benefit is not available to all children in Ireland, and children from the non-white and Traveller
communities may have particular difficulty in accessing eye
care for financial and other reasons. The ‘All Ireland Traveller
Health Study’ identified waiting lists, embarrassment and lack
of information as the main barriers to Travellers in accessing
health services.33 Societal factors which may influence access
to eye care include family responsibilities, parents’ inability to
leave work to attend eye care appointments with their child and
a lack of awareness of the importance of vision checks within
the community.32
It is not clear why children with PVI who had a history of
spectacle wear did not bring their spectacles to school, but such
participants were more likely to be socioeconomically disadvantaged and in the older age group. The present study did not
explore the reasons for children not having spectacles at school,
but issues such as cost of spectacle repair and replacement may
be a factor, and children’s increasing concern over self-image
as they age may also impact. A recent Irish study reported that
parents viewed childhood myopia as a cosmetic disadvantage, a
potential expense and an optical inconvenience, and they were
less concerned about the health risks associated with myopia.34
The NICER study reported almost 24% of participants did not
bring their prescribed spectacles to school,12 34 and in Saudi
Arabia children reported they did not wear their spectacles due
to parental disapproval, spectacle discomfort, visual appearance
and peer pressure.35 The reasons underpinning failure to wear
prescribed spectacles merits further investigation to inform the
development of an eye health awareness programme addressing
spectacle wear and strategies to reduce vulnerability among children who require spectacles to see clearly or maintain ocular
alignment.

Study strengths and limitations

The present study used robust protocols, in line with previous
studies, and achieved relatively high school participation rates
ensuring a representative sample set of the demographic profile
in Ireland schools. Strong (88%) within-school participation
rates were also achieved.

Study limitations

Forty-six per cent of selected schools from the initial sampling
list were unable to facilitate collection of data: school principal
concerns around use of cyclopentolate eye-drops, unavailability
of space or diary clashes with other school-based programmes
were given as reasons for non-participation. The requisite
number of schools was achieved from the reserve list covering
the urban/rural, socioeconomic disadvantaged/advantaged and
primary/postprimary strata. Due to budgetary constraints, the
closed-field Rekto Auto Ref-Keratometer was used as opposed
to the Shin Nippon open-field autorefractor used in the AES and
NICER studies.18 22 36 Under cycloplegic conditions the use of a
closed-field autorefractor on SER outcomes is minimal.37

Conclusion

The IES is the first study to report on refractive error prevalence and visual impairment in schoolchildren living in Ireland.

The IES demonstrates that myopia prevalence is similar to that
reported in comparable studies in Western Europe. However,
the levels of PVI are markedly higher than those reported for
children living in Northern Ireland, and there is a previously
unreported disparity between children needing and wearing
appropriate spectacles in Ireland, indicating suboptimal uptake
of eye care services. Further research is needed to explore
and address individual and societal barriers to good vision in
Ireland.
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